Recent & Upcoming Talks

Target Trial Emulation for Comparing Repeated Treatment Schedules: Pitfalls and Key Decisions featured image

Target Trial Emulation for Comparing Repeated Treatment Schedules: Pitfalls and Key Decisions

Meghan K. Gerety

• Aug 5, 2026 8:30 AM — 10:20 AM • 1 min read

Tradeoffs of Target Trial Emulation for Comparing Repeated Treatment Schedules featured image

Tradeoffs of Target Trial Emulation for Comparing Repeated Treatment Schedules

Meghan K. Gerety

• Mar 15, 2026 2:45 PM — 3:00 PM • 1 min read

Long-Term Comparative Effectiveness of Rituximab vs. Calcineurin Inhibitors for the Treatment of Membranous Nephropathy featured image

Long-Term Comparative Effectiveness of Rituximab vs. Calcineurin Inhibitors for the Treatment of Membranous Nephropathy

Meghan K. Gerety

• Nov 8, 2025 10:00 AM — 12:00 PM • 1 min read

Matched Design with Re-entry and Missingness for Comparative Effectiveness in Membranous Nephropathy featured image

Matched Design with Re-entry and Missingness for Comparative Effectiveness in Membranous Nephropathy

Meghan K. Gerety

• Aug 5, 2025 2:00 PM — 3:50 PM • 1 min read

Long-Term Comparative Effectiveness of Rituximab vs. Calcineurin Inhibitors for the Treatment of Membranous Nephropathy featured image

Long-Term Comparative Effectiveness of Rituximab vs. Calcineurin Inhibitors for the Treatment of Membranous Nephropathy

Meghan K. Gerety

• Feb 26, 2025 3:00 PM — 4:00 PM • 1 min read